GlassScriptPhysician profile
Dana Goldense
NPI 1861939027
$5,381.73
in general payments reported to CMS, 2019-2025
8 companies · $884 in 2025
The $884 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $1,386 · 2023: $1,009 · 2024: $1,856 · 2025: $884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,591 · Consulting Fee: $1,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,590.54 |
| Consulting Fee | $1,158.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,048.81 | 2021-2025 | Aveir, Gallant, Jot Dx |
| Irhythm Technologies, INC. | $815.64 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $768.64 | 2022-2025 | Farapulse, General - Ep, S-Icd System Magnet |
| Medtronic, INC. | $525.95 | 2023-2025 | Cobalt Dr Mri Surescan, Micra, Attain Command + Surevalve |
| Biotronik INC. | $499.40 | 2022-2024 | Acticor 7 Vr-T Dx |
| Impulse Dynamics (USA) INC. | $378.10 | 2023-2024 | Optimizer, Optimizer |
| Biosense Webster, INC. | $208.10 | 2024-2025 | Qdot Micro Catheter, Nuvision Ice Catheter, Carto 3 |
| Elutia, INC. | $137.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Goldense listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.